CA2723704C - Nitric oxide donating prostamides - Google Patents

Nitric oxide donating prostamides Download PDF

Info

Publication number
CA2723704C
CA2723704C CA2723704A CA2723704A CA2723704C CA 2723704 C CA2723704 C CA 2723704C CA 2723704 A CA2723704 A CA 2723704A CA 2723704 A CA2723704 A CA 2723704A CA 2723704 C CA2723704 C CA 2723704C
Authority
CA
Canada
Prior art keywords
ono2
independently selected
alkenyl
alkynyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2723704A
Other languages
English (en)
French (fr)
Other versions
CA2723704A1 (en
Inventor
Francesca Benedini
Stefano Biondi
Valerio Chiroli
Wesley Kwan Mung Chong
Liming Dong
Achim Hans-Peter Krauss
Fabio Nicoli
Ganesh Prasanna
William Francois Vernier
Yi Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicox SA
Original Assignee
Nicox SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox SA filed Critical Nicox SA
Publication of CA2723704A1 publication Critical patent/CA2723704A1/en
Application granted granted Critical
Publication of CA2723704C publication Critical patent/CA2723704C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA2723704A 2008-05-09 2009-05-11 Nitric oxide donating prostamides Active CA2723704C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5208408P 2008-05-09 2008-05-09
US61/052,084 2008-05-09
US13933308P 2008-12-19 2008-12-19
US61/139,333 2008-12-19
PCT/IB2009/005594 WO2009136281A1 (en) 2008-05-09 2009-05-11 Nitric oxide donating prostamides

Publications (2)

Publication Number Publication Date
CA2723704A1 CA2723704A1 (en) 2009-11-12
CA2723704C true CA2723704C (en) 2017-08-22

Family

ID=41020929

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2723704A Active CA2723704C (en) 2008-05-09 2009-05-11 Nitric oxide donating prostamides

Country Status (8)

Country Link
US (1) US8101658B2 (enExample)
EP (1) EP2274279B1 (enExample)
JP (1) JP5401540B2 (enExample)
CN (1) CN102099330B (enExample)
AR (1) AR076731A1 (enExample)
CA (1) CA2723704C (enExample)
ES (1) ES2428387T3 (enExample)
WO (1) WO2009136281A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8519178B2 (en) 2009-06-22 2013-08-27 Johnson Matthey Public Limited Company Method for the purification of prostaglandins
BR112013020719B1 (pt) * 2011-02-14 2018-04-17 Allergan, Inc. Composições de derivados de bimatoprost tipo éster e métodos
EP3421042B1 (en) 2012-03-07 2024-04-17 Beyond Air Ltd Inhalation of nitric oxide for treating respiratory diseases
US9045443B2 (en) 2012-05-31 2015-06-02 Theravance Biopharma R&D Ip, Llc Nitric oxide donor neprilysin inhibitors
WO2016155906A1 (en) 2015-03-31 2016-10-06 Nicox S.A. Nitric oxide donating derivatives of fluprostenol
US10047047B2 (en) 2015-03-31 2018-08-14 Nicox S.A. Nitric oxide donating derivatives of latanoprost free acid
EP3088388A1 (en) 2015-04-30 2016-11-02 NicOx S.A. Nitric oxide donating derivatives of prostaglandins
WO2017042636A1 (en) 2015-09-09 2017-03-16 Advanced Inhalation Therapies (Ait) Ltd. Nitric oxide inhalation therapy for infants with bronchiolitis
CA3043000A1 (en) 2016-11-08 2018-05-17 Bausch & Lomb Incorporated Nitric oxide releasing prostaglandin derivatives for treating normal tension glaucoma
ES2836118T3 (es) 2018-02-21 2021-06-24 Nicox Sa Procedimiento para la preparación de un análogo de prostaglandina donante de óxido nítrico
RU2718744C2 (ru) * 2018-05-17 2020-04-14 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные простагландина F2альфа для снижения внутриглазного давления
SMT202100034T1 (it) 2018-07-12 2021-03-15 Nicox Sa Composizioni oftalmiche contenenti una prostamide che rilascia ossido nitrico
ES2964005T3 (es) * 2019-08-05 2024-04-03 Nicox Sa Procedimiento de preparación de un análogo de prostaglandina donador de óxido nítrico
US20240158345A1 (en) * 2021-02-03 2024-05-16 Nicox S.A. Process for the preparation of a nitric oxide donating prostaglandin analogue
JP2024533601A (ja) 2021-09-20 2024-09-12 ニコックス エス．エー． 神経保護剤としての一酸化窒素放出プロスタミド
CN113943266A (zh) * 2021-11-18 2022-01-18 广州楷石医药有限公司 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途
HRP20241504T1 (hr) 2022-07-07 2025-01-03 Nicox S.A. Industrijski postupak priprave (1s,2e)-3-[(1r,2r,3s,5r)-2-[(2z)-7-(etilamino)-7-okso-2-hepten-1-il]3,5-dihidroksiciklopentil]-1-(2-feniletil)-2-propen-1-ilnog estera 6(nitroksi)heksanske kiseline i produkta visoke čistoće
CN115677549A (zh) * 2022-10-27 2023-02-03 神隆医药（常熟）有限公司 一种贝美前列素手性异构体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6395787B1 (en) * 2000-02-08 2002-05-28 Allergan Sales, Inc. Ocular hypotensive lipids
TWI298257B (en) * 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
SI1480949T1 (sl) * 2002-03-01 2015-09-30 Allergan, Inc. Priprava prostamidov
ES2767136T3 (es) * 2004-01-05 2020-06-16 Nicox Sa Derivados de prostaglandinas
EP1899295A2 (en) * 2005-06-29 2008-03-19 Pfizer, Inc. Prostaglandin derivatives
US20070015838A1 (en) * 2005-07-14 2007-01-18 Allergan, Inc. Cyclopentane n-lower alkyl heptenamide-5-cis-2-(3alpha-hydroxy-5-phenylpentyl)-3, 5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
AR076731A1 (es) 2011-07-06
US8101658B2 (en) 2012-01-24
EP2274279B1 (en) 2013-07-31
CA2723704A1 (en) 2009-11-12
WO2009136281A1 (en) 2009-11-12
CN102099330A (zh) 2011-06-15
EP2274279A1 (en) 2011-01-19
ES2428387T3 (es) 2013-11-07
JP5401540B2 (ja) 2014-01-29
CN102099330B (zh) 2014-04-30
HK1160835A1 (en) 2012-08-17
US20110092590A1 (en) 2011-04-21
JP2011519910A (ja) 2011-07-14

Similar Documents

Publication Publication Date Title
EP2274279B1 (en) Nitric oxide donating prostamides
US12180248B2 (en) Compositions and methods for treating CNS disorders
DE69512891T2 (de) Metalloproteinaseinhibitoren
AU2004313688B2 (en) Prostaglandin nitrooxyderivatives
CA3103711A1 (en) Spirocyclic indane analogues as il-17 modulators
DE69615058T2 (de) Metalloproteinase inhibitoren
CA3064156A1 (en) Spirocyclic indolines as il-17 modulators
EP0997147A1 (en) Amino acid derivatives
JP2018076234A (ja) ピラゾロ［１，５−ａ］ピリミジン化合物
WO2021204800A1 (en) Difluorocyclohexyl derivatives as il-17 modulators
BG64213B1 (bg) Глюкокортикоидселективни противовъзпалителни средства
CN107021887A (zh) 四环素类化合物
WO2019205979A1 (zh) 非天然氨基酸类衍生物、包含其的药物组合物及其制备方法和用途
CS172591A3 (en) Radicicol derivatives, process of their preparation and use
CA3253274A1 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH THE ACTIVITY OF THE LPA RECIPIENT
JP2009500315A (ja) フルオロプロスタグランジンのニトロ誘導体
WO2018089402A1 (en) Tricyclic sulfones as ror gamma modulators
BR112021007041A2 (pt) composto e composição farmacêutica
DE2337630A1 (de) Neue in 15-stellung substituierte prostansaeuren und ester davon, sowie verfahren zu ihrer herstellung
HK1160835B (en) Nitric oxide donating prostamides
WO2003024922A1 (en) Hydroxyfattysulfonic acid analogs
JPWO2008146917A1 (ja) リンコマイシン誘導体及びこれを有効成分とする抗菌剤
EP0432974A1 (en) Cyclic renin inhibitors
EP0432975A1 (en) Cyclic renin inhibitors
CN116669721B (zh) 抗胆碱能药物

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140429

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 16TH ANNIV.) - STANDARD

Year of fee payment: 16

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250423

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250423

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 17TH ANNIV.) - STANDARD

Year of fee payment: 17

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260428

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260428